(Total Views: 312)
Posted On: 07/19/2021 10:39:28 AM
Post# of 36549
From the last PR on 22nd June it looks like Joe is expecting completion of manufacturing and IND submission to increase valuation and then do the IPO .. that is what I understand from below .. if that is case I don’t think we will expect anything to happen until end of July .. I may be misreading it .. thoughts?
NGIO received the valuation as of November 15, 2020, and since then has made significant progress in the vaccine development programs, including completion of the GMP manufacturing of the Ii-Key-SARS-CoV-2 vaccine to potentially increase this valuation. The final lot release of the COVID-19 vaccine from the manufacturer for use in clinical trials is scheduled for July. Stability studies are ongoing to support the IND, which is currently being compiled for submission to FDA.
NGIO received the valuation as of November 15, 2020, and since then has made significant progress in the vaccine development programs, including completion of the GMP manufacturing of the Ii-Key-SARS-CoV-2 vaccine to potentially increase this valuation. The final lot release of the COVID-19 vaccine from the manufacturer for use in clinical trials is scheduled for July. Stability studies are ongoing to support the IND, which is currently being compiled for submission to FDA.
(1)
(0)Scroll down for more posts ▼
